Anatomical Context
Like the three-piece inflatable penile prosthesis, the malleable prosthesis is implanted within the corpora cavernosa — the paired erectile chambers enclosed by the tunica albuginea. Each corpus cavernosum is dilated during surgery to accommodate one semi-rigid rod, which runs the full intracorporal length from the crural base to the glans. The tunica albuginea provides the structural envelope that retains the rod in position and transmits the rod's rigidity to the penile shaft. The corpus spongiosum and urethra on the ventral midline are not entered or disturbed during the procedure.
A malleable prosthesis does not require a fluid reservoir or pump mechanism. The entire device is contained within the two corpora cavernosa — a significant anatomical simplification compared to three-piece IPP systems. This eliminates the need for retropubic reservoir placement, scrotal pump positioning, and the associated tubing connections, substantially reducing operative complexity, operative time, and the anatomical locations susceptible to mechanical failure. The trade-off is that rigidity is permanent in degree — the device maintains the corpora in a state of continuous firmness, and concealment is achieved by manually bending the penis downward against the thigh rather than by hydraulic deflation.
What the Procedure Involves
The procedure follows the same initial steps as three-piece IPP implantation. A penoscrotal incision provides access to the corpora cavernosa. Bilateral corporotomy incisions are made, and each corpus is dilated proximally and distally with Hegar dilators to the measured corporal length. Device length is determined by direct corporotomy measurement, with rear-tip extenders used to fine-tune the fit. The semi-rigid rod — a central metallic or polytetrafluoroethylene cable core covered by medical-grade silicone — is then inserted into each dilated corpus cavernosum, the proximal end seated at the crural base and the distal end positioned at the sub-coronal level. Correct sizing avoids distal rod migration, which can produce visible glans deformity, or proximal shortfall, which reduces rigidity.
The corporotomy incisions are closed with absorbable sutures and the wound is closed in layers. No pump, reservoir, or connecting tubing is placed. Operative time is typically 45 to 60 minutes, somewhat shorter than three-piece IPP surgery. The device is left in the neutral (slightly upward) position at closure. During the post-operative healing period, the patient learns to position the penis inferiorly against the thigh for daily concealment and to position it anterosuperiorly for sexual activity. Penile positioning exercises beginning at 2 to 3 weeks post-operatively train the periprosthetic tissue to accommodate comfortable positional movement.
Candidacy Criteria
The malleable prosthesis is appropriate for all the same organic ED indications as the three-piece IPP — post-prostatectomy ED, diabetic vasculogenic ED, Peyronie's disease with concurrent ED, and severe cavernous fibrosis — with particular advantages for specific patient subgroups. Men with limited manual dexterity due to neurological conditions (multiple sclerosis, spinal cord injury, Parkinson's disease), severe arthritis, or other conditions affecting fine motor coordination are often unable to reliably operate the scrotal pump of a three-piece IPP. For these patients, the malleable prosthesis provides equivalent functional outcome without the operational demands of a hydraulic system. Similarly, men who prioritise device simplicity and longevity over the naturalised flaccid appearance of an IPP may elect a malleable device.
The malleable prosthesis is also a cost-appropriate option for patients without insurance coverage who require surgical treatment but face financial constraints. The lower device cost relative to three-piece IPP systems translates directly to lower total procedure cost. Contraindications are essentially the same as for any intracorporal prosthetic implantation: active infection, uncontrolled coagulopathy, and inadequate corporal anatomy for rod placement. Men with concurrent Peyronie's disease requiring plication or grafting are generally better served by a three-piece IPP that can provide the manual corporoplasty effect of inflation.
Recovery Timeline
Recovery following malleable prosthesis implantation is slightly faster than after three-piece IPP surgery due to the reduced anatomical dissection — no reservoir placement and no scrotal pump pocket are required. Post-operative discomfort is typically mild and managed with oral analgesics for 3 to 5 days. Scrotal and penile swelling resolve within 2 weeks in most patients. Return to sedentary work is possible at 5 to 10 days. Physical exertion involving lower abdominal or perineal engagement is restricted for 3 weeks.
Penile positioning exercises — gently bending the device downward and then returning it to a neutral or upward position — are initiated at 2 to 3 weeks post-operatively to maintain tissue pliability around the implant and to habituate the patient to device operation. Unlike three-piece IPP, there is no formal "activation" visit — the device is functional from the moment of healing. Sexual activity is cleared at the 3 to 4-week post-operative visit contingent on wound healing and comfortable positioning. There is no restriction on frequency of device use once fully healed.
Risks and Complication Profile
The risk profile of malleable prosthesis implantation is broadly similar to three-piece IPP, with device-specific differences. Infection rates in primary implantation with antibiotic-coated devices are 1 to 3%, comparable to IPP. The absence of hydraulic components eliminates mechanical failure as a meaningful risk — the semi-rigid core is not subject to the cycling fatigue or fluid leak that affects inflatable systems. The primary device-specific risk is erosion: the permanently rigid rod exerts continuous low-level pressure on the distal corporal tunica and sub-coronal tissues, and in patients with impaired sensation — particularly those with spinal cord injury, diabetes with peripheral neuropathy, or prior pelvic radiation — this pressure can produce gradual erosion through the tunica albuginea or glans.
Discomfort during positional changes — the mechanical bending required to move the device between the functional and concealed positions — is a patient-reported concern in a minority of cases, particularly in the early post-operative period before periprosthetic tissue has fully accommodated the device. Concealment challenges in certain clothing types or body habitus may reduce patient satisfaction relative to IPP, and this should be addressed explicitly in pre-operative counselling.
Cost Considerations
The total cost of $8,000 to $15,000 is meaningfully lower than three-piece IPP surgery. The primary driver of the cost difference is the device itself: malleable prostheses (AMS Spectra, Coloplast Genesis) are significantly less expensive per unit than three-piece hydraulic systems due to the absence of a pump mechanism, reservoir, and extended tubing. Surgeon and facility fees are comparable to or slightly lower than IPP due to shorter operative time and reduced procedural complexity.
As with three-piece IPP, the malleable prosthesis for documented organic erectile dysfunction may qualify for insurance coverage under major medical plans. Pre-authorisation through the surgeon's billing team is recommended prior to scheduling. For patients without insurance coverage, the malleable prosthesis represents a clinically equivalent alternative to IPP in terms of functional outcome for erectile dysfunction, at a substantially lower self-pay cost.
Selecting a Qualified Surgeon
Malleable prosthesis implantation requires the same core competencies as IPP implantation: precise corporotomy technique, accurate device sizing, corporal dilation without perforation, and wound closure. The absence of reservoir placement and tubing connections does not substantially reduce the skill requirements for the corporotomy and device fitting components. Surgeons should hold ABU board certification and SMSNA active membership, with documented prosthetic urology experience. An andrology fellowship with implant surgery volume is the relevant training credential.
Patients considering malleable versus inflatable prosthesis should request a frank comparative discussion from their surgeon — including the surgeon's personal volume with both device types, patient satisfaction data at their practice, and an honest assessment of which device best suits the individual patient's anatomy, manual dexterity, lifestyle, and financial circumstances. A surgeon who implants both platforms and can provide an unbiased recommendation is preferable to one who exclusively performs one device type.